Dashboard
Manage Tickers

XLRN ACCELERON PHARMA INC

Nasdaq www.acceleronpharma.com


$ -0.93 (-0.52 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 635.42 nm (nm)
DIA $ 476.25 nm (nm)
SPY $ 686.72 nm (nm)
TLT $ 91.08 $ -0.93 (-1.01 %)
GLD $ 362.96 $ -1.38 (-0.38 %)
$ 178.75
-- x --
-- x --
-- - --
$ 108.82 - $ 189.99
7,884,284
na
10.89B
$ 0.82
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-04-2021 09-30-2021 10-Q
2 08-05-2021 06-30-2021 10-Q
3 05-06-2021 03-31-2021 10-Q
4 02-25-2021 12-31-2020 10-K
5 11-05-2020 09-30-2020 10-Q
6 08-06-2020 06-30-2020 10-Q
7 05-11-2020 03-31-2020 10-Q
8 02-27-2020 12-31-2019 10-K
9 11-06-2019 09-30-2019 10-Q
10 08-05-2019 06-30-2019 10-Q
11 05-09-2019 03-31-2019 10-Q
12 02-27-2019 12-31-2018 10-K
13 10-30-2018 09-30-2018 10-Q
14 08-02-2018 06-30-2018 10-Q
15 05-08-2018 03-31-2018 10-Q
16 02-27-2018 12-31-2017 10-K
17 11-07-2017 09-30-2017 10-Q
18 08-03-2017 06-30-2017 10-Q
19 05-08-2017 03-31-2017 10-Q
20 03-01-2017 12-31-2016 10-K
21 11-03-2016 09-30-2016 10-Q
22 08-04-2016 06-30-2016 10-Q
23 05-05-2016 03-31-2016 10-Q
24 02-25-2016 12-31-2015 10-K
25 11-04-2015 09-30-2015 10-Q
26 08-06-2015 06-30-2015 10-Q
27 05-07-2015 03-31-2015 10-Q
28 03-02-2015 12-31-2014 10-K
29 11-07-2014 09-30-2014 10-Q
30 08-12-2014 06-30-2014 10-Q
31 05-15-2014 03-31-2014 10-Q
32 03-17-2014 12-31-2013 10-K
33 11-14-2013 09-30-2013 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Merck Announces Expiration Of Hart-Scott-R...
11/17/2021 11:46:52

the-daily-biotech-pulse-double-dose-of-positive-tidings-for-merck-alkermes-slips-on-partial-termination-of-jj-licensing-deal-amgen-migraine-drug-data
The Daily Biotech Pulse: Double Dose Of Po...
11/09/2021 13:13:10

Here's a roundup of top developments in the biotech space over the last 24 hours:

Core News & Articles
Merck Reports Pending Acquisition Of Accel...
11/08/2021 21:32:07

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that its pending acquisition of Acceleron ...

acceleron-pharma-q3-eps-116-down-from-066-yoy-sales-3420m-up-from-2256m-yoy
Acceleron Pharma Q3 EPS $(1.16) Down From ...
11/04/2021 20:10:22

Acceleron Pharma (NASDAQ:XLRN) reported quarterly losses of $(1.16) per share. This is a 75.76 percent decrease over losses of ...

merck-pushes-acceleron-buyout-by-refiling-for-antitrust-review
Merck Pushes Acceleron Buyout By Refiling ...
11/01/2021 21:10:40

Core News & Articles
Avoro Capital Issues Open Letter To Fellow...
10/28/2021 12:11:12

Avoro Capital Advisors ("Avoro"), a long-term and collaborative investor in life sciences and biotechnology companies, ...

acceleron-q3-reblozyl-net-sales-160m
Acceleron Q3 REBLOZYL Net Sales $160M
10/27/2021 11:50:09

bristol-myers-pledges-to-offload-acceleron-shares-bloomberg
Bristol Myers Pledges To Offload Acceleron...
10/21/2021 17:10:54

Core News & Articles
Bloomberg Reported Late Wednesday Bristol-...
10/21/2021 09:54:22

https://www.bloomberg.com/news/articles/2021-10-21/bristol-myers-said-to-plan-acceleron-stake-exit-with-merck-deal

Core News & Articles
Acceleron Pharma Shareholder Darwin Global...
10/20/2021 12:07:22

Believes proposed $180/share offer price is too low and that Acceleron’s share price as a standalone company will exceed offer ...

Core News & Articles
Holocene Advisors Says Believes Merck's Pr...
10/13/2021 19:32:10

Long-term Holder Does Not Intend to Tender Shares into Merck's Offer Holocene Advisors, LP ("Holocene"), a fundame...

Core News & Articles
Merck Begins Tender Offer To Acquire Accel...
10/12/2021 10:48:44

expert-ratings-for-acceleron-pharma
Expert Ratings For Acceleron Pharma
10/07/2021 16:20:37

Analysts have provided the following ratings for Acceleron Pharma (NASDAQ:XLRN) within the last quarter:

benzingas-top-ratings-upgrades-downgrades-for-october-7-2021
Benzinga's Top Ratings Upgrades, Downgrade...
10/07/2021 14:02:38

 

jefferies-initiates-coverage-on-acceleron-pharma-with-hold-rating-announces-price-target-of-180
Jefferies Initiates Coverage On Acceleron ...
10/07/2021 09:01:13

Jefferies analyst Akash Tewari initiates coverage on Acceleron Pharma (NASDAQ:XLRN) with a Hold rating and announces Price T...

acceleron-pharma-13d-filing-from-avoro-capital-shows-73-stake-in-co
Acceleron Pharma 13D Filing From Avoro Cap...
10/05/2021 16:33:50

where-acceleron-pharma-stands-with-analysts
Where Acceleron Pharma Stands With Analysts
10/04/2021 18:12:34

Analysts have provided the following ratings for Acceleron Pharma (NASDAQ:XLRN) within the last quarter:

Core News & Articles
UPDATE: Raymond James On Acceleron Pharma ...
10/04/2021 15:19:59

benzingas-top-ratings-upgrades-downgrades-for-october-4-2021
Benzinga's Top Ratings Upgrades, Downgrade...
10/04/2021 14:02:09

 

raymond-james-downgrades-acceleron-pharma-to-market-perform
Raymond James Downgrades Acceleron Pharma ...
10/04/2021 11:16:14

Raymond James analyst Danielle Brill downgrades Acceleron Pharma (NASDAQ:XLRN) from Strong Buy to Market Perform.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION